Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
5
×
boston blog main
life sciences
national blog main
boston top stories
clinical trials
drugs
biotech
fda
financing
venture capital
abbvie
accelerated approval
access biotechnology
access industries
acute hepatic porphyria
akero therapeutics
aldehyde
aldeyra therapeutics
allergic conjunctivitis
allopregnanolone
alnylam pharmaceuticals
aminolevulinic acid
anemia
apellis pharmaceuticals
aragon pharmaceuticals
atlas ventures
blood diseases
blood disorders
brexanolone
brian macdonald
corey goodman
disc medicine
drug development
dry eye disease
elizabeta nemeth
funding
givosiran
harmony biosciences
incubation
What
medicine
5
×
new
5
×
drug
data
fda
advance
aldeyra
alnylam
anemia
approach
approved
bags
biotechs
blood
body
brexanolone
capital
carry
cells
cleared
closer
depression
devastating
disc
disclosed
disorder
eye
far
fast
fighting
filing
having
health
inflammation
interference
investing
investors
iron
launches
lead
Language
unset
Current search:
boston
×
medicine
×
new
×
@xconomy.com
4 years ago
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
